Research Interests

• I have been engaged in the clinical and research work of hematological diseases for more than 20 years, and focus on the pathogenesis and clinical management of myelodysplastic syndromes (MDS). Our research team is engaging in explore the crosstalk between the genetic and epigenetic regulators and signaling pathways that underlying in the mechanism of MDS, involving cell apoptosis, autophagy, inflammation, as well as immune response, and have published more than 20 academic papers on international journals, including Nature Communications, Cell Death and Disease, British Journal of Haematology, etc.